Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer

BACKGROUND: Gemcitabine plus nab-paclitaxel (GnP) has been a standard treatment for unresectable pancreatic cancer (uPC); however, the current treatment status and usefulness in older adults with uPC remain unclear. Therefore, we aimed to investigate the patient background and compare the efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Satoshi, Suzuki, Motoko, Ueno, Makoto, Maruki, Yuta, Okano, Naohiro, Todaka, Akiko, Ozaka, Masato, Tsuji, Kunihiro, Shioji, Kazuhiko, Doi, Keitaro, Kojima, Yasushi, Tsumura, Hidetaka, Tanaka, Kazunari, Higuchi, Hajime, Kawabe, Ken, Imaoka, Hiroshi, Yamashita, Tatsuya, Miwa, Haruo, Nagano, Hiroaki, Arima, Shiho, Hayashi, Hideyuki, Naganuma, Atsushi, Yamaguchi, Hironori, Hisano, Terumasa, Umemoto, Kumiko, Ishii, Shuji, Nakashima, Koji, Suzuki, Rei, Kitano, Yohei, Misumi, Toshihiro, Furuse, Junji, Ishii, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Gastrointestinal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526497/
https://www.ncbi.nlm.nih.gov/pubmed/35946841
http://dx.doi.org/10.1093/oncolo/oyac157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526497/
https://www.ncbi.nlm.nih.gov/pubmed/35946841
http://dx.doi.org/10.1093/oncolo/oyac157

Ejemplares similares